Teladoc Health, Inc. (NYSE:TDOC) Receives Consensus Recommendation of "Hold" from Brokerages

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) has received an average recommendation of "Hold" from the nineteen analysts that are currently covering the stock, MarketBeat.com reports. Twelve investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $9.60.

Several analysts have recently commented on TDOC shares. The Goldman Sachs Group decreased their price objective on Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Piper Sandler cut their target price on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a research report on Thursday, May 1st. Bank of America cut their target price on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 28th. Finally, Citigroup cut their target price on Teladoc Health from $11.00 to $8.75 and set a "neutral" rating on the stock in a research report on Friday, April 25th.

Insider Activity

In related news, insider Carlos Nueno sold 3,958 shares of the firm's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $6.86, for a total value of $27,151.88. Following the transaction, the insider now directly owns 17,645 shares of the company's stock, valued at approximately $121,044.70. This trade represents a 18.32% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Adam C. Vandervoort sold 5,808 shares of the firm's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $6.86, for a total transaction of $39,842.88. Following the completion of the transaction, the insider now directly owns 69,773 shares in the company, valued at $478,642.78. This represents a 7.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 29,667 shares of company stock worth $220,901 in the last ninety days. Company insiders own 0.58% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Robeco Institutional Asset Management B.V. lifted its stake in Teladoc Health by 21.8% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider's stock worth $6,365,000 after purchasing an additional 125,111 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Teladoc Health by 18.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider's stock worth $22,213,000 after purchasing an additional 384,528 shares in the last quarter. Geode Capital Management LLC lifted its stake in Teladoc Health by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock worth $35,894,000 after purchasing an additional 22,664 shares in the last quarter. Commonwealth Equity Services LLC lifted its stake in Teladoc Health by 35.7% in the 4th quarter. Commonwealth Equity Services LLC now owns 113,563 shares of the health services provider's stock worth $1,032,000 after purchasing an additional 29,903 shares in the last quarter. Finally, Xponance Inc. lifted its stake in Teladoc Health by 23.8% in the 4th quarter. Xponance Inc. now owns 13,861 shares of the health services provider's stock worth $126,000 after purchasing an additional 2,661 shares in the last quarter. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Stock Up 0.7%

Shares of TDOC traded up $0.05 during midday trading on Friday, hitting $7.11. 4,941,623 shares of the company's stock traded hands, compared to its average volume of 6,264,066. Teladoc Health has a 1 year low of $6.35 and a 1 year high of $15.21. The firm's fifty day moving average is $7.18 and its 200-day moving average is $9.16. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $1.25 billion, a price-to-earnings ratio of -1.23 and a beta of 1.82.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.